Who are the 2 candidates Massie is talking about at 1:26?
Cooper
@yankees_28th
If you thought you loved @RepThomasMassie before; you didn’t love him enough.
3:56 PM · Dec 30, 2023
https://twitter.com/yankees_28th/status/1741201544056303860
1) One candidate supporting all the bad policy?
2) Another trying to make money off this selling data, collecting information on people?
Michael Gorecki
@MichaelGorecki
Granite Staters are fired up for @RonDeSantis! #NH #FITN
1:09 PM · Dec 30, 2023
https://twitter.com/MichaelGorecki/status/1741159554962854317
Matt Wolking
@MattWolking
Hey @LauraLoomer will you be shaming Donald Trump for supporting the FBI building?
Or will he cut off your paycheck if you do that?
4:36 PM · Dec 30, 2023
https://twitter.com/MattWolking/status/1741211617163870635
Ramaswamy company pitched governments on effort to install universal covid patient records surveillance database
Datavant sought to create a universal database for governments that displays "every patient who has been tested for Covid-19."
JORDAN SCHACHTEL
JUN 6, 2023
https://www.dossier.today/p/ramaswamy-company-pitched-governments
Before rebranding as a warrior for free speech and a passionate crusader for privacy rights, newly announced presidential contender Vivek Ramaswamy was pitching the U.S. and world governments on his efforts to install a broad, centralized database of private medical records.
In a pursuit forged through one of his subsidiary companies, a “health information” data mining outfit called Datavant, Ramaswamy’s outfit pursued the establishment of a single national and global database for all covid-related patient health records.
Through a partnership with Snowflake, a San Francisco based cloud computing company, Ramaswamy wanted to “fight covid-19” by manufacturing a “single repository of all the real-world medical data” thanks to the production of a “national data infrastructure” of private and public patient records, all without the consent of the actual patients.
Datavant claimed the records would be anonymized through their internal systems and that the broad database would only be available to researchers and government officials. However, some weren’t buying the sales pitch, citing gross violations of medical privacy. Moreover, none of the methods to supposedly anonymize records were made open source for review.
Nonetheless Ramaswamy’s Datavant sought to profit off of the hysteria and violate basic ethical standards in the process. They succeeded in establishing a partnership with the National Institutes of Health (NIH).
While some companies were happy to contribute to the Datavant endeavor, citing the “national emergency” as the ultimate precedent for violating patient consent standards, many others balked at the idea, citing privacy issues.
Anthem Inc (now known as Elevance Health), the second largest health insurance company in the U.S., rejected the appeal to deliver customer records into a national and global database. When reached by the Wall Street Journal, an Anthem spokesperson said that “Anthem takes the security of its data and the personal information of health plan members very seriously.”
“Datavant’s proposed registry would be free for government and academic researchers to access, and would aim to include every patient who has been tested for Covid-19, the disease caused by the new coronavirus,” The WSJ story reported. “The consortium is aiming to have data covering 80% of U.S. medical claims, including those submitted to private insurers as well as Medicaid and Medicare Advantage.”
Harlan Krumholz, a cardiologist at Yale University, expressed concern about Ramaswamy’s data mining effort, telling Endpoints News: “This is highly sensitive information and the effort is important, but it is important to know the details.”
Datavant later helped to establish a Covid-19 research database. However, like most of Ramaswamy’s previous business ventures, the end product was not remotely successful. The database is linked to a handful of incredibly shoddy covid-19 studies.
On the campaign trail, Mr Ramaswamy has presented himself as a fierce privacy advocate and “free speech absolutist.” Nonetheless, his blunder-heavy business record shows a man who has long been invested in financing and developing tools to invade sovereignty and personal privacy.
For more on Ramaswamy’s paradoxical advocacy, and his continually changing political posturing, read Vetting Vivek Ramaswamy in The Dossier
"Datavant inc began spearheading one such effort in late March"
Companies Seek to Pool Medical Records to Create Coronavirus Patient Registry
Database would make medical histories for U.S. Covid-19 patients available to government and academic researchers
Patience Haggin
Updated April 8, 2020 7:12 pm ET
https://www.wsj.com/articles/companies-seek-to-pool-medical-records-to-create-coronavirus-patient-registry-11586381102
"Several health-care and software companies are seeking to create a registry of Covid-19 patients by pooling medical records from across the country, aiming to study how the disease is spreading, which population groups are most vulnerable and how effective proposed treatments are, people familiar with the matter said.
San Francisco-based Datavant Inc., which specializes in compiling medical data from a variety of sources, began spearheading one such effort in late March, one of the people said. Health-care technology companies Allscripts Healthcare Solutions Inc. MDRX 0.10%increase; green up pointing triangle and Change Healthcare Inc. said they have committed to donate data for the effort. Health insurance provider Anthem Inc. has been contacted about contributing medical claims data, an Anthem spokeswoman said."
>Datavant claimed the records would be anonymized through their internal systems and that the broad database would only be available to researchers and government officials. However, some weren’t buying the sales pitch, citing gross violations of medical privacy. Moreover, none of the methods to supposedly anonymize records were made open source for review.
Damn!
>On the campaign trail, Mr Ramaswamy has presented himself as a fierce privacy advocate and “free speech absolutist.” Nonetheless, his blunder-heavy business record shows a man who has long been invested in financing and developing tools to invade sovereignty and personal privacy.
Exclusive: Vivek Ramaswamy Supported COVID Segregation
Pedro L. Gonzalez
https://threadreaderapp.com/thread/1729913580466626893.html
🧵
“Could we tolerate a national system in which certain people on the basis of a biomarker are segregated?”
That sounds like an excerpt from a science fiction novel about a medical dystopia. But it’s a quote from Vivek Ramaswamy, the biopharma entrepreneur and Republican presidential candidate.
In April 2020, as the U.S. went into lockdown, Ramaswamy said he would be open to that kind of system to determine who could “go back to normal life.” He described it as an “inequity,” but concluded that “everyone stands to benefit from it.” Ramaswamy made the comments during an episode of Rockefeller Client Insights, the podcast of Rockefeller Capital Management.
A concept like that is sharply at odds with the image of the civil libertarian he has cultivated during the primary. It also raises questions about his anti-establishment bona fides.
During the podcast, Ramaswamy talked about different aspects of the coronavirus outbreak with Gregory J. Fleming, the president and CEO of Rockefeller Capital Management. Fleming asked him what a “path to normalcy” might look like, given what he described as a “potentially extended timeline” for the rollout of vaccines and treatments. The country was then more than 15 days into “15 days to slow the spread.”
“One path to normalcy and a path that I’d like to see further progress made on is broad rollout of our antibody tests,” Ramaswamy said. He corrected himself and continued:
“It’s not our company; I’m saying, as a society, rolling out the antibody tests such that we actually get our arms around what portion of the population is already immune through exposures that they may not have even known that they had. It might be 10 percent, it might be 20 percent, we might discover that it is some higher number. Those people are gonna be able to get back to work pretty quickly, get back to normal life because effectively they have the immunity badge, they have a badge in the form of their antibodies that protect them best we know from reinfection.
On the flip side, you then have the people who don’t have immunity, and the question is those who are negative on the antibody tests, what happens with them? Now, this has been—I’ve had discussions in the last few days with policymakers, a couple of people in Congress, one U.S. Senator, and I think this is not lost on folks. But I think one early topic that’s come up is, could we tolerate a national system in which certain people on the basis of a biomarker are segregated? To say you can’t go back to normal life, where certain people get a head start. Is that an inequity we would tolerate? I personally think that it is better than the status quo if we can send 10 or 20 percent of the people back on the basis of having immunity that’s proven on the basis of a lab-based result that’s now available. That’s a good thing, and everyone stands to benefit from it.”
A draft for discussion obtained by Contra shows Ramaswamy pitched this strategy to policymakers.
“After its apex of COVID-19 cases, each state should start to administer universal antibody testing to determine which individuals have immunity to SARS-Cov-2 and which individuals do not,” he wrote. “Individuals with immunity can return to normal life, be released from social distancing practices, and help restart the economy.”
“States should also have a well-designed plan for who should be released from social distancing norms to help revive the economy in advance of the availability of a COVID-19 vaccine,” he added."